Cargando…

Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients

Antituberculosis (anti-TB) drug development is dependent on informative trials to secure the development of new antibiotics and combination regimens. Clofazimine (CLO) and pyrazinamide (PZA) are important components of recommended standard multidrug treatments of TB. Paradoxically, in a phase IIa tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faraj, Alan, Svensson, Robin J., Diacon, Andreas H., Simonsson, Ulrika S. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179644/ https://www.ncbi.nlm.nih.gov/pubmed/32122887 http://dx.doi.org/10.1128/AAC.01905-19

Ejemplares similares

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
por: Mockeliunas, Laurynas, et al.
Publicado: (2023)

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
por: Ayoun Alsoud, Rami, et al.
Publicado: (2023)

Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023)

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
por: Alffenaar, Jan-Willem C., et al.
Publicado: (2022)

Clofazimine pharmacokinetics in patients with TB: dosing implications
por: Abdelwahab, Mahmoud Tareq, et al.
Publicado: (2020)

Clofazimine: A Promising Inhibitor of Rabies Virus
por: Wu, Jiajing, et al.
Publicado: (2021)

Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions
por: Faraj, Alan, et al.
Publicado: (2020)

Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
por: Anderson, Ronald, et al.
Publicado: (2018)

Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example
por: Keutzer, Lina, et al.
Publicado: (2020)

A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses
por: Svensson, Robin J., et al.
Publicado: (2017)

Improved power for TB Phase IIa trials using a model-based pharmacokinetic–pharmacodynamic approach compared with commonly used analysis methods
por: Svensson, Robin J., et al.
Publicado: (2017)

Clofazimine-induced Hair Pigmentation
por: Philip, Mariam, et al.
Publicado: (2012)

Extemporaneously compounded liquid formulations of clofazimine
por: Taneja, R., et al.
Publicado: (2023)

Clofazimine for Rapidly Growing Mycobacterial Infections
por: Carey, George B, et al.
Publicado: (2017)

Single Crystal FLIM Characterization of Clofazimine Loaded in Silica-Based Mesoporous Materials and Zeolites
por: Angiolini, Lorenzo, et al.
Publicado: (2019)

Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug
por: Faraj, Alan, et al.
Publicado: (2022)

Clofazimine induced methemoglobinemia – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022)

Clofazimine induced pigmentation in leprosy patches
por: Chavhan, Samiksha Deepak, et al.
Publicado: (2022)

Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling
por: van Wijk, Rob C., et al.
Publicado: (2023)

Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
por: Stemkens, Ralf, et al.
Publicado: (2023)

Rapid Recovery of Clofazimine-Loaded Nanoparticles with Long-Term Storage Stability as Anti-Cryptosporidium Therapy
por: Feng, Jie, et al.
Publicado: (2018)

Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19
por: van Wijk, Rob C., et al.
Publicado: (2023)

A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis
por: Clewe, Oskar, et al.
Publicado: (2020)

Clofazimine-induced enteropathy in a patient of leprosy
por: Singh, Harminder, et al.
Publicado: (2013)

Clofazimine-induced premaculopathy in a vitiliginous patient
por: Kasturi, Nirupama, et al.
Publicado: (2016)

Clofazimine for Treatment of Mycobacterium abscessus Infections in Children
por: Adler-Shohet, Felice C, et al.
Publicado: (2017)

Clofazimine-induced methemoglobinemia: A rare incidence
por: Asif, Ahmed, et al.
Publicado: (2018)

Role of Clofazimine in Treatment of Mycobacterium avium Complex
por: Nasiri, Mohammad Javad, et al.
Publicado: (2021)

The top 100 cited studies on bacterial persisters: A bibliometric analysis
por: Ju, Yuan, et al.
Publicado: (2022)

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
por: Abulfathi, Ahmed A., et al.
Publicado: (2021)

Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline
por: Villellas, Cristina, et al.
Publicado: (2017)

Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro
por: Zhang, Shuo, et al.
Publicado: (2017)

Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn
por: Wedgwood, Stephen, et al.
Publicado: (2015)

Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche
por: McGuffin, Sarah A, et al.
Publicado: (2017)

Novel Administration of Clofazimine for the Treatment of Mycobacterium avium Infection
por: Valinetz, Ethan, et al.
Publicado: (2020)

Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
por: Zhang, Lei, et al.
Publicado: (2023)

Residual Spinal Cord Compression Following Hemilaminectomy and Mini-Hemilaminectomy in Dogs: A Prospective Randomized Study
por: Svensson, Gustaf, et al.
Publicado: (2017)

Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients
por: Faraj, Alan, et al.
Publicado: (2023)

How best to explain unexpected arrangements of the atrioventricular valves?
por: Anderson, Robert H
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fkbsiii1rual45j49bvv0d3smc